Author contributions MY contributed to the collection, analysis, and interpretation of data as well as manuscript preparation
Other risk contributors include: long-standing diabetes with end-organ damage, hypertension, older age, severe sleep apnea, and any condition that predisposes to low optic nerve perfusion
However, compounded medications are not FDA-approved finished products
Peptides maintain excellent safety profiles with minimal side effects
Store immediately: Place the vial in the refrigerator as soon as possible
GLP-1 therapy can improve: Type 2 diabetes Blood pressure Fatty liver disease Sleep apnea PCOS Cholesterol Joint pain Mobility Quality of life Many patients also report increased energy and confidence as they lose weight